Abstract
The etiology of Crohn's disease (CD) remains controversial. It is hypothesized that CD is the result of an abnormal immune response to the gut flora in genetically susceptible hosts. However, an infectious etiology has not been completely ruled out. Antibiotics have been utilized with some success to modify the course of the disease. Here, we report a patient with CD and pyoderma gangrenosum refractory to standard therapy, including biologics, who achieved remission with a combination of rifaximin, gentamicin and metronidazole.
Original language | English (US) |
---|---|
Pages (from-to) | 25-28 |
Number of pages | 4 |
Journal | Case Reports in Gastroenterology |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - May 22 2015 |
Keywords
- Combination therapy
- Crohn's disease
- Pyoderma gangrenosum
ASJC Scopus subject areas
- Gastroenterology